The Cancer Genome Atlas (TCGA) Research Network is providing data and genome analysis to the cancer research community which is supporting new discoveries and accelerating the pace of cancer research. Below is a list of selected articles that describe the broad impact of TCGA on cancer research.
- April 06, 2010
House Committee Convenes Hearing on NCI Research
Former NCI Deputy Director Dr. Anna Barker testified before the House of Representatives Committee on Energy and Commerce, Subcommittee on Health at a hearing held on March 23. Focusing on progress in molecular biology and advanced technologies, Dr. Barker provided an overview of TCGA emphasizing that the biggest challenge to expanding TCGA is obtaining high-quality biospecimens.
- February 09, 2010
Cancer Bulletin Profile: Meet Dr. Raju Kucherlapati
The Cancer Bulletin profiles Raju Kucherlapati, Ph.D., a Paul C. Cabot Professor of Genetics and Professor of Medicine at Harvard Medical School, and a principal investigator for TCGA. Dr. Kucherlapati is working toward characterizing the genetic and genomic changes found in cancer samples with the goal of understanding how cancer develops and to identify meaningful subtypes of cancer in order to determine which drugs are most likely to work.
- January 28, 2010
CBS Where America Stands: Cancer
NIH Director, Dr. Francis Collins, is interviewed by Katie Couric on CBS Evening News, Jan. 28, drawing upon the discoveries being made by TCGA researchers to improve cancer treatments.
- January 26, 2010
Brain Cancer, Like Other Cancers, Has Distinct Subtypes
Molecular findings are presenting new avenues for brain cancer treatment. This article references TCGA's research defining four subtypes of glioblastoma that respond differently to therapy.
- January 25, 2010
In Tough Economic Times, NIH Head Looks to Clinic
NIH Director, Dr. Francis Collins, discusses his plans for NIH and how programs like TCGA will bring different approaches to cancer treatments.
- January 19, 2010
TCGA Identifies Distinct Subtypes of Deadly Brain Cancer That May Lead to New Treatment Strategies
TCGA researchers identified four distinct molecular subtypes of glioblastoma multiforme (GBM), and demonstrated that response to aggressive chemotherapy and radiation differed by subtype.
- December 22, 2009
Children's Hospital Major Player in Tumor War
The Research Institute at Nationwide Children’s Hospital is selected as one of two Biospecimen Core Resources for TCGA tumor collection. Thousands of samples from 250 hospitals in the United States and other countries will be sent to the Columbus-based institution for potential use in TCGA research.
- December 01, 2009
Program Looks for Genetic Markers of Cancer
Community cancer centers play a critical role in the success of TCGA. Since community cancer centers see the majority of cancer patients, they are instrumental in consenting patients to donate their tissue to the TCGA program so that researchers can identify the genomic changes in these cancers.
- December 01, 2009
Recovery Act Investment in TCGA Creates Prospective Tissue Accrual Network
Thanks to the investment of Recovery Act funds, the ability to obtain the quality and quantity of biospecimens required for TCGA will be significantly improved and the pace of TCGA research accelerated through the creation of a prospective tissue accrual network.
- November 27, 2009
ASCO Report: Clinical Cancer Advances 2009
The American Society of Clinical Oncology (ASCO) issued its Clinical Cancer Advances 2009. TCGA findings on the genetics of glioblastoma are highlighted as a notable advance in nervous system cancers.